Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1992 Nov 21;305(6864):1269–1272. doi: 10.1136/bmj.305.6864.1269

Discovery of antibodies.

M B Llewelyn 1, R E Hawkins 1, S J Russell 1
PMCID: PMC1883762  PMID: 1477573

Abstract

Passive immunisation has been used in clinical practice since the end of last century, mainly for prophylaxis. Success of early treatments was marred by anaphylactic reactions and serum sickness because antibodies or antitoxins were not raised in humans. Recombination of gene segments during antibody synthesis means that specific antibodies for numerous antigens can be produced from a limited gene pool. Killer lymphocytes, phagocytes, and complement then bind to the constant region of the antibody facilitating elimination of the pathogen. Development of a method of obtaining large quantities of antibodies against a specific antigen (monoclonal antibodies) offers the possibility of initiating host defence mechanisms against any unwanted antigen, though some problems still remain in preventing the body from attacking the monoclonal antibody.

Full text

PDF
1269

Images in this article

1272p1272-a
on p.1272

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BROWNING C. H. Emil Behring and Paul Ehrlich: their contributions to science. Nature. 1955 Apr 2;175(4457):570–contd. doi: 10.1038/175570a0. [DOI] [PubMed] [Google Scholar]
  2. Berek C., Milstein C. Mutation drift and repertoire shift in the maturation of the immune response. Immunol Rev. 1987 Apr;96:23–41. doi: 10.1111/j.1600-065x.1987.tb00507.x. [DOI] [PubMed] [Google Scholar]
  3. DALE H. Paul Ehrlich, born March 14, 1854. Br Med J. 1954 Mar 20;1(4863):659–663. doi: 10.1136/bmj.1.4863.659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dreyer W. J., Bennett J. C. The molecular basis of antibody formation: a paradox. Proc Natl Acad Sci U S A. 1965 Sep;54(3):864–869. doi: 10.1073/pnas.54.3.864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gronski P., Seiler F. R., Schwick H. G. Discovery of antitoxins and development of antibody preparations for clinical uses from 1890 to 1990. Mol Immunol. 1991 Dec;28(12):1321–1332. doi: 10.1016/0161-5890(91)90034-h. [DOI] [PubMed] [Google Scholar]
  6. Karpas A., Hill F., Youle M., Cullen V., Gray J., Byron N., Hayhoe F., Tenant-Flowers M., Howard L., Gilgen D. Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome. Proc Natl Acad Sci U S A. 1988 Dec;85(23):9234–9237. doi: 10.1073/pnas.85.23.9234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
  8. MACNALTY A. S. Emil von Behring, born March 15, 1854. Br Med J. 1954 Mar 20;1(4863):668–670. doi: 10.1136/bmj.1.4863.668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Pascual V., Capra J. D. Human immunoglobulin heavy-chain variable region genes: organization, polymorphism, and expression. Adv Immunol. 1991;49:1–74. doi: 10.1016/s0065-2776(08)60774-9. [DOI] [PubMed] [Google Scholar]
  10. Poljak R. J., Amzel L. M., Avey H. P., Chen B. L., Phizackerley R. P., Saul F. Three-dimensional structure of the Fab' fragment of a human immunoglobulin at 2,8-A resolution. Proc Natl Acad Sci U S A. 1973 Dec;70(12):3305–3310. doi: 10.1073/pnas.70.12.3305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Steinitz M., Izak G., Cohen S., Ehrenfeld M., Flechner I. Continuous production of monoclonal rheumatoid factor by EBV-transformed lymphocytes. Nature. 1980 Oct 2;287(5781):443–445. doi: 10.1038/287443a0. [DOI] [PubMed] [Google Scholar]
  12. Stokes J., Maris E. P., Gellis S. S. CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XI. THE USE OF CONCENTRATED NORMAL HUMAN SERUM GAMMA GLOBULIN (HUMAN IMMUNE SERUM GLOBULIN) IN THE PROPHYLAXIS AND TREATMENT OF MEASLES. J Clin Invest. 1944 Jul;23(4):531–540. doi: 10.1172/JCI101518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Williams A. F., Galfrè G., Milstein C. Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes. Cell. 1977 Nov;12(3):663–673. doi: 10.1016/0092-8674(77)90266-5. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES